Connection

Charles Bennett to Cisplatin

Back to Details
This is a "connection" page, showing publications Charles Bennett has written about Cisplatin.
Charles Bennett
Connection Strength
0.111
Cisplatin
  1. Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial. Cancer Invest. 2000; 18(3):261-8.
    View in: PubMed
    Score: 0.039
  2. Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest. 1999; 17(8):559-65.
    View in: PubMed
    Score: 0.036
  3. Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol. 1998 Dec; 71(3):369-75.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.